a.kowalski
TL2 Moderator · Osaka
Contributes reviews on supplier material. Based in Osaka.
Joined 12 December 2024 · last posted 7h
89 posts, newest first. Showing up to 150.
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #47 · Practice › Reconstitution · 28 Jul 2026 · 3 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
What to bring: records that a clinician can actually use Replied, post #20 · Clinical › Prescriber conversations · 26 Jul 2026 · 7 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #116 · Analytics › Impurities & related substances · 26 Jul 2026 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #76 · Practice › Side effects · 26 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Asking a follow-up: new topic or new reply? Replied, post #61 · Start Here › How to Ask · 19 Jul 2026 · 5 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #104 · Sourcing › Vendor reports · 18 Jul 2026 · 17 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #45 · Documentation › Doc review · 15 Jul 2026 · 1 like Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
A single out-of-range value on an otherwise normal panel Replied, post #70 · Clinical › Bloodwork · 9 Jul 2026 · 8 likes Coming back to post #68, because the follow-up matters more than the original answer. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel.…
-
Request: a per-category review queue Replied, post #86 · Meta › Feature requests · 7 Jul 2026 · 25 likes This follows post #83 rather than contradicting it. Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought…
-
How much context is too much context in a first post? Replied, post #27 · Start Here › How to Ask · 6 Jul 2026 · 12 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #79 · Compounds › Repair & healing peptides · 26 Jun 2026 · 22 likes I read post #77 twice before replying, because I had assumed the opposite. BPC-157: the preclinical literature is extensive, mostly from a small number of research…
-
Coming back to: Time to steady state after a dose increase Replied, post #82 · Pharmacology › Pharmacokinetics · 21 Jun 2026 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Pages past their review date, listed — does this still hold? Replied, post #20 · Meta › Wiki maintenance · 21 Jun 2026 · 25 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current.
-
Pooling trials with different estimands Replied, post #20 · Evidence › Meta-analyses · 12 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #17 · Compounds › Retatrutide · 9 Jun 2026 · 13 likes post #16 answers the question as asked. The question underneath it is different. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #54 · Practice › Storage & stability · 5 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #31 · Access › Insurance & coverage · 30 May 2026 · 4 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #16 · Access › Pricing · 29 May 2026 · 0 likes I read post #14 twice before replying, because I had assumed the opposite. Subscription services and subscriptions: some online clinics bundle compounds into…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #2 · Access › Insurance & coverage · 21 May 2026 · 7 likes Picking up the opening post: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #124 · Devices › Syringes & needles · 16 May 2026 · 32 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
Coming back to: A structured critique template this community uses Replied, post #10 · Evidence › Study critique · 12 May 2026 · 1 like What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
Revisiting: What pooling buys you and what it destroys Replied, post #15 · Evidence › Meta-analyses · 6 May 2026 · 10 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Designing a personal experiment that could change your mind — one year on Replied, post #31 · Research Methods › N-of-1 designs · 9 Apr 2026 · 1 like Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #28 · Meta › Announcements · 9 Apr 2026 · 28 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #32 · Evidence › Journal club · 4 Apr 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #23 · Compounds › Secretagogues & GH axis · 31 Mar 2026 · 0 likes Picking up post #20: that is the part I would want checked first. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #31 · Practice › Administration · 29 Mar 2026 · 7 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
A calculator that gives a right answer to the wrong question Replied, post #11 · Data & Tools › Calculators · 22 Mar 2026 · 0 likes I read post #9 twice before replying, because I had assumed the opposite. Storage lookup: which conditions (temperature, time) are you considering storing in, and how…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 2 Mar 2026 · 27 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #31 · Compounds › Other compounds · 20 Feb 2026 · 16 likes This follows post #28 rather than contradicting it. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another.…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #132 · Analytics › Home & field testing · 11 Feb 2026 · 9 likes I read post #130 twice before replying, because I had assumed the opposite. Why third-party testing is stronger: a home test run by the person who made the compound is…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #79 · Sourcing › Red flags · 5 Feb 2026 · 4 likes post #78 answers the question as asked. The question underneath it is different. Inability to trace lots: if you ask "where was this synthesised, by whom, under what…
-
[2026 update] Long-time reader, first-time poster Replied, post #43 · Lounge › Introductions · 19 Jan 2026 · 0 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #31 · Practice › Storage & stability · 19 Jan 2026 · 22 likes Coming back to post #29, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #49 · Practice › Side effects · 28 Dec 2025 · 0 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #8 · Sourcing › Vendor reports · 25 Dec 2025 · 28 likes Coming back to post #6, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Micro-titration: a disputed topic, argued properly Replied, post #14 · Practice › Dosing & titration · 21 Dec 2025 · 4 likes Coming back to post #12, because the follow-up matters more than the original answer. Holding a dose indefinitely: the trials did not study indefinite holding at a…
-
The decimal-point error, and the habit that catches it Replied, post #71 · Practice › Reconstitution · 16 Dec 2025 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #24 · Practice › Dosing & titration · 7 Dec 2025 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #16 · Practice › Interactions · 5 Dec 2025 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
EMA product information as a primary source Replied, post #22 · Regional › European Union · 1 Nov 2025 · 10 likes Coming back to post #20, because the follow-up matters more than the original answer. Italy: AIFA controls reimbursement through a note system. Weight-management…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #10 · Outcomes › Body composition · 30 Oct 2025 · 6 likes This follows post #7 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Journal club: LEADER as the historical anchor Started this topic · Evidence › Journal club · 29 Oct 2025 · 3 likes Journal club: LEADER as the historical anchor Writing it up because I had to work it out twice and would rather nobody else did. Comparing STEP 1 ( N Engl J Med , 2021)…
-
Appeal templates and why they are deliberately unemotional Replied, post #19 · Access › Insurance & coverage · 19 Oct 2025 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #4 · Devices › Pens & autoinjectors · 8 Oct 2025 · 6 likes Worth separating two things that post #3 runs together. Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to…
-
Liver enzymes drifting down and what that usually means Replied, post #14 · Clinical › Bloodwork · 26 Sep 2025 · 11 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #58 · Evidence › Study critique · 14 Sep 2025 · 0 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #3 · Evidence › Journal club · 31 Aug 2025 · 4 likes Worth separating two things that the opening post runs together. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective…
-
Coming back to: Official shortage notices and what they authorise Replied, post #85 · Access › Shortages · 10 Aug 2025 · 15 likes Coming back to post #83, because the follow-up matters more than the original answer. Shortage predictions: regulators and suppliers issue shortage alerts before they…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #14 · Practice › Dosing & titration · 20 Jul 2025 · 25 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Measurement error in home scales, with a worked standard deviation — a second dataset Started this topic · Research Methods › Statistics · 13 Jul 2025 · 0 likes Measurement error in home scales, with a worked standard deviation — a second dataset — setting out what I have, and where I think it stops being reliable. Comparing…
-
Which panel is worth repeating and which is worth ignoring Replied, post #45 · Clinical › Bloodwork · 24 Jun 2025 · 19 likes Worth separating two things that post #41 runs together. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #17 · Analytics › Method validation · 17 Jun 2025 · 18 likes post #16 answers the question as asked. The question underneath it is different. Range: the concentration range over which the method has been validated. Going outside…
-
A report I filed that turned out to be wrong, and the correction Replied, post #102 · Sourcing › Vendor reports · 14 Jun 2025 · 23 likes On post #98 — agreed on the reasoning, with one qualification. Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently,…
-
[2026 update] Constipation management, with a dietitian's contribution Replied, post #4 · Practice › Side effects · 10 Jun 2025 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. Injection site reaction: local erythema, nodules, or induration at injection sites is…
-
Criticising the method without criticising the authors — one year on Replied, post #4 · Evidence › Study critique · 29 May 2025 · 16 likes On post #2 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
Pre-registering a personal experiment, seriously Replied, post #16 · Research Methods › N-of-1 designs · 26 May 2025 · 33 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
Travel coolers and how long they really hold — the long version Replied, post #24 · Devices › Cold chain · 23 May 2025 · 0 likes Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.
-
Titles that describe the question, not the situation Replied, post #14 · Start Here › How to Ask · 21 May 2025 · 1 like Worth separating two things that post #10 runs together. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #5 · Compounds › Oral incretins · 8 May 2025 · 3 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Coming back to: Official shortage notices and what they authorise Replied, post #3 · Access › Shortages · 8 May 2025 · 17 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Reading an MS report that only gives you a single number Replied, post #66 · Analytics › Mass spectrometry · 30 Apr 2025 · 0 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Water content on a certificate and why it changes the arithmetic Replied, post #3 · Analytics › COA interpretation · 21 Apr 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #26 · Access › Insurance & coverage · 18 Mar 2025 · 14 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #78 · Access › International · 4 Mar 2025 · 32 likes This follows post #75 rather than contradicting it. Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #20 · Evidence › Journal club · 2 Mar 2025 · 0 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #14 · Analytics › COA interpretation · 20 Feb 2025 · 15 likes Picking up post #11: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #9 · Access › Pricing · 13 Feb 2025 · 22 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Distinguishing a deletion sequence by mass alone Replied, post #72 · Analytics › Mass spectrometry · 10 Feb 2025 · 11 likes I read post #70 twice before replying, because I had assumed the opposite. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #43 · Clinical › Bloodwork · 4 Feb 2025 · 7 likes Worth separating two things that post #39 runs together. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #74 · Sourcing › Regulatory · 30 Jan 2025 · 7 likes This follows post #71 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #4 · Clinical › Comorbidities · 26 Jan 2025 · 2 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Second pass at: Regression to the mean in progress reports Replied, post #31 · Research Methods › Statistics · 21 Jan 2025 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Individual participant data versus aggregate data Replied, post #14 · Evidence › Meta-analyses · 10 Jan 2025 · 0 likes post #13 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #112 · Compounds › Tirzepatide · 27 Dec 2024 · 17 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #13 · Practice › Interactions · 16 Dec 2024 · 32 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #19 · Data & Tools › Calculators · 14 Dec 2024 · 15 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Triple agonism: additive, synergistic, or neither? Replied, post #3 · marked as the solution · Compounds › Retatrutide · 10 Dec 2024 · 7 likes Worth separating two things that the opening post runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Promotion criteria, and the one that stops most nominations Replied, post #111 · Documentation › Doc review · 12 Nov 2024 · 29 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #24 · Compounds › Repair & healing peptides · 10 Nov 2024 · 0 likes Coming back to post #22, because the follow-up matters more than the original answer. BPC-157: the preclinical literature is extensive, mostly from a small number of…
-
Irish differences from the UK position Replied, post #66 · Regional › UK & Ireland · 30 Oct 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #44 · Access › Shortages · 10 Oct 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #74 · Practice › Dosing & titration · 1 Oct 2024 · 0 likes On post #70 — agreed on the reasoning, with one qualification. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological…
-
Converting between mg/mL and units per dose, both directions Replied, post #36 · Practice › Reconstitution · 1 Oct 2024 · 10 likes post #35 is right about the mechanism and I think understates the practical bit. Choosing a concentration on purpose rather than by accident: starting with "I want to…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #23 · Compounds › Tirzepatide · 27 Sep 2024 · 13 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #9 · Practice › Interactions · 6 Aug 2024 · 8 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #50 · Compounds › Retatrutide · 19 Jul 2024 · 10 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #22 · Evidence › Journal club · 13 Jul 2024 · 2 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #26 · Practice › Interactions · 10 Jul 2024 · 21 likes I read post #24 twice before replying, because I had assumed the opposite. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K)…